» Articles » PMID: 14974752

B-lymphocytes and Co-stimulatory Molecules in Mycobacterium Tuberculosis Infection

Overview
Specialty Pulmonary Medicine
Date 2004 Feb 21
PMID 14974752
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Setting: The immunological mechanisms that lead to the control of Mycobacterium tuberculosis infection are not well known.

Objective: To study the role of lymphocyte subsets and co-stimulatory molecules in M. tuberculosis infection.

Design: In 35 patients with pulmonary tuberculosis (PTB) and their contacts, 29 persons with tuberculin skin test conversion (TSTC) and 20 healthy individuals with negative tuberculin skin test (NTST), we studied T-lymphocyte subsets (CD3, CD4, CD8, alphabetaTCR and gammadeltaTCR), B-cells, monocytes and co-stimulatory molecules CD28 and CD86 in peripheral blood. The results were analysed at univariate and multivariate level through discriminant analysis.

Results: At univariate level, compared with TSTC and NTST, PTB patients presented a decrease in CD4+ T-cells (P = 0.002), and B-cells (P = 0.02 and 0.001, respectively). With regard to NTST subjects, PTB patients also showed a decrease in the percentage of CD86+ monocytes (P = 0.02) and an increase in the percentage of CD86+ B-lymphocytes (P = 0.02). At multivariate level, CD4+ T-lymphocytes showed statistical differences between PTB and TSTC subjects (P = 0.001). B-lymphocytes were discriminant between PTB and NTST (P < 0.001) and between TSTC and NTST individuals (P = 0.01).

Conclusion: The number of total CD4+ T-cells is the best discriminant parameter for distinguishing between disease and infection, whereas the B-cell count is the best between healthy and infected individuals.

Citing Articles

B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles.

Krause R, Ogongo P, Tezera L, Ahmed M, Mbano I, Chambers M Commun Biol. 2024; 7(1):584.

PMID: 38755239 PMC: 11099031. DOI: 10.1038/s42003-024-06282-7.


Joint Modeling of Longitudinal Outcome and Competing Risks: Application to HIV/AIDS Data.

Najafi Ghobadi K, Mahjub H, Poorolajal J, Shakiba E, Khassi K, Roshanaei G J Res Health Sci. 2023; 23(1):e00571.

PMID: 37571942 PMC: 10422140. DOI: 10.34172/jrhs.2023.106.


Impact of Infection on Human B Cell Compartment and Antibody Responses.

La Manna M, Shekarkar-Azgomi M, Badami G, Tamburini B, Dieli C, Di Carlo P Cells. 2022; 11(18).

PMID: 36139482 PMC: 9497247. DOI: 10.3390/cells11182906.


Mechanism of COVID-19-Related Proteins in Spinal Tuberculosis: Immune Dysregulation.

Chen L, Liu C, Liang T, Ye Z, Huang S, Chen J Front Immunol. 2022; 13:882651.

PMID: 35720320 PMC: 9202521. DOI: 10.3389/fimmu.2022.882651.


B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis.

Rijnink W, Ottenhoff T, Joosten S Front Immunol. 2021; 12:640168.

PMID: 33679802 PMC: 7930078. DOI: 10.3389/fimmu.2021.640168.